Bill Search

  • Introduced
    Feb 18, 2021
  • Passed House
  • Passed Senate
  • Signed into Law
HF 1183
Minnesota House Bill
Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.
Last Action
House • Apr 09, 2021: Author stricken Boe
Latest bill text

Official Summary/Bill Text

Comments on Bill

Tweets

Whip Lists

Do you support this bill?
Yay Nay
Sponsors:
Votes
Actions
  • Apr 09, 2021 | House
    • Author stricken Boe
  • Mar 25, 2021 | House
    • Author added Greenman
  • Mar 11, 2021 | House
    • Committee report, to adopt and re-refer to Ways and Means
  • Mar 08, 2021 | House
    • Author added Klevorn
  • Mar 04, 2021 | House
    • Committee report, to adopt as amended and re-refer to State Government Finance and Elections
    • Author added Bierman
  • Feb 25, 2021 | House
    • Committee report, to adopt as amended and re-refer to Health Finance and Policy
    • Author added Boe
  • Feb 18, 2021 | House
    • Introduction and first reading, referred to Commerce Finance and Policy
Documents